JCRB0147 JKT-beta-del
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0147 | Cell Name | JKT-beta-del |
---|---|---|---|
Profile | The JKT-beta-del cell line isolated from the Jurkat cells{5011} by a cell sorter and lacks the surface expression of the T-cell receptor alpha/beta/CD3 complex. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | Age | ||
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | T-cell leukemia | Metastasis | |
Tissue Metastasized | Genetics | Deletion of rearranged T-cell receptor(TCR) C beta gene | |
Life Span | infinite | Crisis PDL | |
Morphology | lymphoblast-like | Character | Jurkat cell clone with a lack of surface expresshion of TCR alpha/beta/CD3 complex {5012, 5010} |
Classify | tumor | Established by | Kyoizumi,S. |
Registered by | Kyoizumi,S. | Regulation for Distribution | normal |
Comment | Year | 1999 | |
Medium | RPMI1640 with 10% heat inactivated fetal calf serum. | Methods for Passages | Subculture once a week at split ratio of 1/10. |
Cell Number on Passage | split ratio = 1/10 | Race | |
CO2 Conc. | 5 % | Tissue Sampling | blood |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | not tested | ||||||
CMV | - | parvoB19 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
EBV | - | HBV | - | ||||||
HHV6 | - | HTLV-1 | - | ||||||
HHV7 | - | HTLV-2 | - | ||||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | NT | ||||||
Notes |
Reference | |
---|---|
Pubmed id:10365913 | Mutant p53: epigenetic mutator of the T-cell receptor via induction of methylation. Iwamoto KS,Mizuno T,Seyama T,Kyoizumi S Mol Carcinog. 1999 Jun;25(2):113-21 |
Pubmed id:1972177 | Spontaneous loss and alteration of antigen receptor expression in mature CD4+ T cells. Kyoizumi S,Akiyama M,Hirai Y,Kusunoki Y,Tanabe K,Umeki S J Exp Med. 1990 Jun 1;171(6):1981-99 |
Pubmed id:6778951 | Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. Gillis S,Watson J J Exp Med. 1980 Dec 1;152(6):1709-19 |
Images |
---|
LOT Information
Cell No. | JCRB0147 | Cell Name | |
---|---|---|---|
LOT No. | 03082005 | Lot Specification | distribution |
Medium | RPMI1640 medium with heat-inactivated fetal bovine serum (FBS lot; GIBCO 3762782S) | Temperature | 37 C |
Cell Density at Seeding | 2 x 10^5 cells/ml (1 x 10^5 at log phase) | Methods for Passages | dilution |
Doubling Time | approx. 28.5 hrs | Cell Number in Vial (cells/1ml) | 4.3 x 10^6 |
Viability at cell freezing (%) | 97.5 | Antibiotics Used | free |
Passage Number | P8 at bank | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% inact. FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0147 | Cell Name | JKT-beta-del |
---|---|---|---|
LOT No. | 04272000 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal calf serum (Intergen RB2405). | Temperature | 37 C |
Cell Density at Seeding | 1.4 x 10^5 cells/sq.cm. | Methods for Passages | Cells subcultured by simple dilution. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.4 x 10^6 |
Viability at cell freezing (%) | 98.9 | Antibiotics Used | free |
Passage Number | P6* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | LDH, NP, G6PD(type A). Human. |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:9 D13S317:8,10,11 D7S820:8,10 D16S539:11,12 VWA:18,19 TH01:6,10 AM:X TPOX:8,10 CSF1PO:11 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | Culture medium containing 5% DMSO. | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB0147 | Cell Name | JKT-beta-del |
---|---|---|---|
LOT No. | 12132018 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 3 - 4 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture) |
Doubling Time | approx. 25 hrs. | Cell Number in Vial (cells/1ml) | 2.5 x 10^6 |
Viability at cell freezing (%) | 92.6 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 92.6 | Additional information |
Cell No. | JCRB0147 | Cell Name | JKT-beta-del |
---|---|---|---|
LOT No. | 02012021 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO Cat#11875) with 10% heat inactivated fetal bovine serum(SIGMA,Cat#172012,Lot#12J396) | Temperature | 37 C |
Cell Density at Seeding | 1.82-2.26x10^5 cells/ml | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.99x10^6 |
Viability at cell freezing (%) | 94 | Antibiotics Used | free |
Passage Number | p8* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:9 D13S317:8,10,11 D7S820:8,10 D16S539:11,12 VWA:18,19 TH01:6,9.3 AM:X TPOX:8,10 CSF1PO:11 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 97 | Additional information |
Images |
---|